Eltrombopag (Promacta), a platelet-enhancing drug indicated for the treatment of thrombocytopenia, has been shown to increase erythrocyte production in patients with aplastic anemia who were non-responders to immunosuppressants
The underlying mechanism involved thioredoxin 1-induced activation of mTORC1, which facilitated GPX4 synthesis and decreased ferroptosis
This is enough to essentially "reset" the biological clock
GMO-free and free from 14 allergens: Sunflower lecithin as the sole carrier, without soy, gluten, lactose or animal-derived ingredients
This leads to a greater reliance on glycolysis, which serves to not only generate ATP but also metabolic intermediates to feed the pentose phosphate pathway
The liver uses this antioxidant to process environmental toxins and metabolic waste